Europe Immunodiagnostics Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product [Enzyme-Linked Immunosorbent Assays (ELISA), Chemiluminescence Immunoassays (CLIA), Radioimmunoassays (RIA), and Others], Clinical Indication (Infectious Diseases, Hepatitis+HIV, Endocrinology, Gastrointestinal, Metabolics, and Others), and End User (Hospitals, Clinics, Diagnostic Laboratories, Academic & Research Institutes, and Others)     

Code: BMIRE00027867 | Pages: 222 | Industry: Biotechnology | Date: Jan 2023 | Type: Regional

The Europe immunodiagnostics market is expected to grow from US$ 5,734.92 million in 2022 to US$ 8,686.76 million by 2028; it is estimated to grow at a CAGR of 7.2% from 2022 to 2028.

 

Increasing Use of Point-of-Care Immunodiagnostics Drives Europe Immunodiagnostics Market Growth

 

Point-of-care testing (POCT) has become critical to patient-centric healthcare due to the need for rapid diagnostic results to determine the accurate and faster treatment. A shift from centralized point-of-care testing to decentralized testing for chronic and infectious patients has resulted in convenient patient access to these diagnostics. The current approach to diagnose and monitor chronic conditions or detect pathogens such as bacteria and viruses is immunoassay testing. Advanced point-of-care devices enable rapid screening of up to three components from a single sample. Also, the point-of-care diagnostics (POCD) inclined toward mobile healthcare (mH) smart devices could revolutionize personalized healthcare monitoring and management, paving the way for next-generation POCTs. Infectious disease management can be significantly improved by POCTs, especially in developing countries where access to timely medical care is challenging and healthcare infrastructure is outdated and sparse. Additionally, the technologically developed diagnostic kits lead to fewer manual errors. Innovative immunodiagnostic products are being developed by several market players. For instance, Thermo Fisher Scientific has developed immunodiagnostic products such as enzyme-linked immunoassay (ELISA) reagents and buffers, antibodies and detection probes, linking mechanisms, blocking buffers and detergents, detection substrates, and capture surfaces, as well as services such as bioconjugation and detection. Further, on September 1, 2020, Roche launched SARS-CoV-2 Rapid Antigen Test. The test is used in POC settings for symptomatic and asymptomatic people to help healthcare professionals identify the infection within 15 minutes in people suspected of carrying SARS-CoV-2. Likewise, the use of immunodiagnostics in cancer treatment is also increasing. In oncology, an immunodiagnostic test can confirm the presence of a solid tumor by detecting known tumor-associated antigens or antibodies. These advantages and indications are a few factors driving the Europe immunodiagnostics market.

 

Europe Immunodiagnostics Market Growth Overview

 

The Europe immunodiagnostic market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. The market growth in the region is characterized by the high prevalence of chronic diseases in major European countries, a surge in demand for effective immunoassay analyzers, and the introduction of technologically advanced analyzers. For instance, in December 2019, Eurofins Abraxis—a biotechnology company—launched an automated ELISA Analyzer, CAAS Cube—a single plate data analysis system—to facilitate enhanced data analysis and customize settings to accommodate laboratory testing requirements. The German immunodiagnostic market has been witnessing substantial growth due to its supportive healthcare policies and the presence of a huge geriatric population. According to the UN population data, 1 out of every 20 Germans is aged above 80 years, and the number is expected to reach 6 out of every 20 people by 2050. The risk of developing chronic diseases, such as cardiovascular diseases (CVDs), diabetes, and neurovascular disorders, increases with age. According to World Cancer Research Fund, in the UK, 387,820 people were diagnosed with cancer in 2019. The most common types of cancer in Germany are breast cancer, prostate cancer, colorectum (large bowel) cancer, lung cancer, and bladder cancer. These five cancer types accounted for ~57% of all new cancer diagnoses in Germany. Therefore, the rising prevalence of cancer in the country leads to a growing demand for disease diagnostics.

 

Europe Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

Europe Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

Get more information on this report :

Europe Immunodiagnostics Market Segmentation

 

The Europe immunodiagnostics market is segmented based on product, clinical indication, end user, and country.  

 

Based on product, the Europe immunodiagnostics market is segmented into enzyme-linked immunosorbent assays (ELISA), chemiluminescence immunoassays (CLIA), radioimmunoassay (RIA), and others. The enzyme-linked immunosorbent assays (ELISA) segment registered the largest share of the market in 2022.

 

Based on clinical indication, the Europe immunodiagnostics market is segmented into infectious diseases, hepatitis+HIV, endocrinology, gastrointestinal, metabolics and others. The infectious diseases segment registered the largest share of the market in 2022.

 

Based on end user, the Europe immunodiagnostics market is segmented into hospitals, clinics, diagnostics laboratories, academic and research institutes, and others. The hospital segment registered the largest share of the market in 2022.

 

Based on country, the Europe immunodiagnostics market is segmented into Germany, France, Italy, the UK, Spain, and the Rest of Europe. Germany dominated the market in 2022.

 

Abbott Laboratories; bioMerieux SA; Danaher Corp; DiaSorin S.p.A.; F. Hoffmann-La Roche Ltd; PerkinElmer Inc.; Shenzhen Mindray Bio-Medical Electronics Co., Ltd.; Siemens Healthineers AG; Svar Life Science AB; and Thermo Fisher Scientific Inc are the leading companies operating in the Europe immunodiagnostics market.

1.           Introduction

1.1         Study Scope

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Europe Immunodiagnostics Market – By Product

1.3.2        Europe Immunodiagnostics Market – By Clinical Indication

1.3.3        Europe Immunodiagnostics Market – By End User

1.3.4        Europe Immunodiagnostics Market– By Country

2.           Europe Immunodiagnostics Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Europe Immunodiagnostics Market– Market Landscape

4.1         Overview

4.2         Europe PEST Analysis

4.3         Experts Opinion

5.           Europe Immunodiagnostics Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Increasing Prevalence of Infectious Diseases

5.1.2        Growing Use of Point-of-Care Immunodiagnostics

5.2         Market Restraints

5.2.1        Inadequate Reimbursement Scenario

5.3         Market Opportunities

5.3.1        Rising Focus on R&D Investment and Expansion by Key Players

5.4         Future Trends

5.4.1        Technological Advancements in Immunodiagnostics

5.5         Impact Analysis

6.           Immunodiagnostics Market– Europe Analysis

6.1         Europe Immunodiagnostics Market Revenue Forecast and Analysis

7.           Europe Immunodiagnostics Market Analysis – by Product

7.1         Overview

7.2         Europe Immunodiagnostics Market, By Product, 2021 & 2028 (%)

7.3         Enzyme-linked immunosorbent assays (ELISA)

7.3.1        Overview

7.3.2        Enzyme-linked immunosorbent assays (ELISA): Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

7.4         Chemiluminescence immunoassays (CLIA)

7.4.1        Overview

7.4.2        Chemiluminescence immunoassays (CLIA): Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

7.4.3        Vitamin D Assay

7.4.3.1          Overview

7.4.3.2          Vitamin D Assay: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

7.4.4        HIV Detection

7.4.4.1          Overview

7.4.4.2          HIV Detection: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

7.4.5        HIV Ag/Ab Combo assay

7.4.5.1          Overview

7.4.5.2          HIV Ag/Ab Combo assay: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

7.4.6        Other Tests

7.4.6.1          Overview

7.4.6.2          Other Tests: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

7.5         Radioimmunoassays (RIA)

7.5.1        Overview

7.5.2        Radioimmunoassays (RIA): Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

7.6         Others

7.6.1        Overview

7.6.2        Others: Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

8.           Europe Immunodiagnostics Market Analysis – Clinical Indication

8.1         Overview

8.2         Europe Immunodiagnostics Market Share by Clinical Indication - 2021 & 2028 (%)

8.3         Infectious Diseases:

8.3.1        Overview

8.3.2        Infectious Diseases: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.3        COVID-19

8.3.3.1          Overview

8.3.3.2          COVID-19: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.4        Tuberculosis

8.3.4.1          Overview

8.3.4.2          Tuberculosis: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.5        Lyme

8.3.5.1          Overview

8.3.5.2          Lyme: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.6        Infection Management

8.3.6.1          Overview

8.3.6.2          Infection Management: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.7        Zika

8.3.7.1          Overview

8.3.7.2          Zika: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.8        Treponema

8.3.8.1          Overview

8.3.8.2          Treponema: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.9        TORCH

8.3.9.1          Overview

8.3.9.2          TORCH: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.10     Measles and Mumps

8.3.10.1       Overview

8.3.10.2       Measles and Mumps: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.11     VZV

8.3.11.1       Overview

8.3.11.2       VZV: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.12     EBV

8.3.12.1       Overview

8.3.12.2       EBV: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.4         Hepatitis+HIV:

8.4.1        Overview

8.4.2        Hepatitis+HIV: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.5         Gastrointestinal

8.5.1        Overview

8.5.2        Gastrointestinal: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.6         Metabolics

8.6.1        Overview

8.6.2        Metabolics: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.7         Endocrinology

8.7.1        Overview

8.7.2        Endocrinology: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.7.3        Hypertension

8.7.3.1          Overview

8.7.3.2          Hypertension: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.7.4        Growth

8.7.4.1          Overview

8.7.4.2          Growth: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.7.5        Diabetes

8.7.5.1          Overview

8.7.5.2          Diabetes: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.7.6        Thyroid

8.7.6.1          Overview

8.7.6.2          Thyroid: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.7.7        Reproductive Endocrinology

8.7.7.1          Overview

8.7.7.2          Reproductive endocrinology: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.8         Others

8.8.1        Overview

8.8.2        Others: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

9.           Europe Immunodiagnostics Market Analysis – End User

9.1         Overview

9.2         Europe Immunodiagnostics Market Share by End User - 2021 & 2028 (%)

9.3         Hospitals

9.3.1        Overview

9.3.2        Hospitals: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

9.4         Clinics

9.4.1        Overview

9.4.2        Clinics: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

9.5         Diagnostic Laboratories

9.5.1        Overview

9.5.2        Diagnostic Laboratories: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

9.6         Academic and Research Institutes

9.6.1        Overview

9.6.2        Academic and Research Institutes: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

9.7         Others

9.7.1        Overview

9.7.2        Others: Immunodiagnostics Market Revenue and Forecast to 2028 (US$ Million)

10.        Europe Immunodiagnostics Market Revenue and Forecast to 2028– by Country

10.1      Overview

10.1.1     Europe: Immunodiagnostics Market, by Country, 2021 & 2028 (%)

10.1.1.1       Germany: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.1.1       Germany: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.1.2       Germany Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)

10.1.1.1.2.1    Germany Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2028 (USD Million)

10.1.1.1.3       Germany Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)

10.1.1.1.3.1    Germany Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

10.1.1.1.3.2    Germany Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)

10.1.1.1.4       Germany: Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.1.2       France: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.1       France: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.2       France Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.2.1    France Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.3       France Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.3.1    France Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.3.2    France Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.4       France Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.1.3       UK: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.1       UK: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.2       UK Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.2.1    UK Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.3       UK Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.3.1    UK Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.3.2    UK Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.4       UK Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.1.4       Italy: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.4.1       Italy: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.4.2       Italy Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)

10.1.1.4.2.1    Italy Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) – Revenue and Forecast to 2028 (USD Million)

10.1.1.4.3       Italy Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)

10.1.1.4.3.1    Italy Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

10.1.1.4.3.2    Italy Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)

10.1.1.4.4       Italy Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.1.5       Spain: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.5.1       Spain: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.5.2       Spain Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)

10.1.1.5.2.1    Spain Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) – Revenue and Forecast to 2028 (USD Million)

10.1.1.5.3       Spain Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)

10.1.1.5.3.1    Spain Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

10.1.1.5.3.2    Spain Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)

10.1.1.5.4       Spain Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

10.1.1.6       Rest of Europe: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.6.1       Rest of Europe: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.6.2       Rest of Europe Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)

10.1.1.6.2.1    Rest of Europe Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) – Revenue and Forecast to 2028 (USD Million)

10.1.1.6.3       Rest of Europe Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)

10.1.1.6.3.1    Rest of Europe Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

10.1.1.6.3.2    Rest of Europe Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)

10.1.1.6.4       Rest of Europe Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

11.        Europe Immunodiagnostics Market –Industry Landscape

11.1      Overview

11.2      Inorganic Growth Strategies

11.2.1     Overview

11.3      Organic Growth Strategies

11.3.1     Overview

12.        Company Profiles

12.1      Abbott Laboratories

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      F. Hoffmann-La Roche Ltd

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      DiaSorin S.p.A.

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      Danaher Corp

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Thermo Fisher Scientific Inc

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      PerkinElmer Inc.

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      bioMerieux SA

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9      Svar Life Science AB

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Products and Services

12.9.4     Financial Overview

12.9.5     SWOT Analysis

12.9.6     Key Developments

12.10   Siemens Healthineers AG

12.10.1  Key Facts

12.10.2  Business Description

12.10.3  Products and Services

12.10.4  Financial Overview

12.10.5  SWOT Analysis

12.10.6  Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

 

 

LIST OF TABLES

Table 1.             Europe Immunodiagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Table 2.             Germany Immunodiagnostics Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 3.             Germany Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)– Revenue and Forecast to 2028 (USD Million)

Table 4.             Germany Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)

Table 5.             Germany Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

Table 6.             Germany Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)

Table 7.             Germany Immunodiagnostics Market, by End User- Revenue and Forecast to 2028 (USD Million)

Table 8.             France Immunodiagnostics Market, by Product -Revenue and Forecast to 2028 (USD Million)

Table 9.             France Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) -Revenue and Forecast to 2028 (USD Million)

Table 10.          France Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)

Table 11.          France Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

Table 12.          France Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)

Table 13.          France Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 14.          UK Immunodiagnostics Market, by Product -Revenue and Forecast to 2028 (USD Million)

Table 15.          UK Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) -Revenue and Forecast to 2028 (USD Million)

Table 16.          UK Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)

Table 17.          UK Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

Table 18.          UK Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)

Table 19.          UK Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 20.          Italy Immunodiagnostics Market, by Product -Revenue and Forecast to 2028 (USD Million)

Table 21.          Italy Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) -Revenue and Forecast to 2028 (USD Million)

Table 22.          Italy Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)

Table 23.          Italy Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

Table 24.          Italy Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)

Table 25.          Italy Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 26.          Spain Immunodiagnostics Market, by Product -Revenue and Forecast to 2028 (USD Million)

Table 27.          Spain Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) -Revenue and Forecast to 2028 (USD Million)

Table 28.          Spain Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)

Table 29.          Spain Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

Table 30.          Spain Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)

Table 31.          Spain Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 32.          Rest of Europe Immunodiagnostics Market, by Product -Revenue and Forecast to 2028 (USD Million)

Table 33.          Rest of Europe Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA) -Revenue and Forecast to 2028 (USD Million)

Table 34.          Rest of Europe Immunodiagnostics Market, by Clinical Indication – Revenue and Forecast to 2028 (USD Million)

Table 35.          Rest of Europe Immunodiagnostics Market, by Infectious Diseases – Revenue and Forecast to 2028 (USD Million)

Table 36.          Rest of Europe Immunodiagnostics Market, by Endocrinology – Revenue and Forecast to 2028 (USD Million)

Table 37.          Rest of Europe Immunodiagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 38.          Recent Inorganic Growth Strategies in the Immunodiagnostics Market

Table 39.          Recent Organic Growth Strategies in the Immunodiagnostics Market

Table 40.          Glossary of Terms, Immunodiagnostics Market

 

 

LIST OF FIGURES

Figure 1.           Europe Immunodiagnostics Market Segmentation

Figure 2.           Europe Immunodiagnostics Market Segmentation, By Country

Figure 3.           Europe Immunodiagnostics Market Overview

Figure 4.           Europe Immunodiagnostics Market, by Product

Figure 5.           Europe Immunodiagnostics Market, by Country

Figure 6.           Europe PEST Analysis

Figure 7.           Europe Immunodiagnostics Market: Impact Analysis of Drivers and Restraints

Figure 8.           Europe Immunodiagnostics Market– Revenue Forecast and Analysis – 2020 - 2028

Figure 9.           Europe Immunodiagnostics Market, by Product, 2021 & 2028 (%)

Figure 10.        Enzyme-linked immunosorbent assays (ELISA): Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 11.        Chemiluminescence immunoassays (CLIA): Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 12.        Vitamin D Assay: Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 13.        HIV Detection: Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 14.        HIV Ag/Ab Combo assay: Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 15.        Other Tests: Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 16.        Radioimmunoassays (RIA): Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 17.        Others: Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 18.        Europe Immunodiagnostics Market Share by Clinical Indication - 2021 & 2028 (%)

Figure 19.        Infectious Diseases: Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 20.        COVID-19: Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21.        Tuberculosis: Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 22.        Lyme: Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 23.        Infection Management: Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 24.        Zika: Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 25.        Treponema: Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 26.        TORCH: Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 27.        Measles and Mumps: Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 28.        VZV: Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 29.        EBV: Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 30.        Hepatitis+HIV: Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 31.        Gastrointestinal: Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 32.        Metabolics: Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 33.        Endocrinology: Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 34.        Hypertension: Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 35.        Growth: Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 36.        Diabetes: Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 37.        Thyroid: Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 38.        Reproductive endocrinology: Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 39.        Others: Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 40.        Europe Immunodiagnostics Market Share by End User - 2021 & 2028 (%)

Figure 41.        Hospitals: Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 42.        Clinics: Europe Immunodiagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 43.        Diagnostic Laboratories: Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 44.        Academic and Research Institutes: Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 45.        Others: Europe Immunodiagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 46.        Europe: Immunodiagnostics Market, by Key Country – Revenue (2021) (USD Million)

Figure 47.        Europe: Immunodiagnostics Market, by Country, 2021 & 2028 (%)

Figure 48.        Germany: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 49.        France: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 50.        UK: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 51.        Italy: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 52.        Spain: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

Figure 53.          Rest of Europe: Immunodiagnostics Market – Revenue and Forecast to 2028 (USD Million)

  1. Abbott Laboratories
  2. bioMerieux SA
  3. Danaher Corp
  4. DiaSorin S.p.A.
  5. F. Hoffmann-La Roche Ltd
  6. PerkinElmer Inc.
  7. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  8. Siemens Healthineers AG
  9. Svar Life Science AB
  10. Thermo Fisher Scientific Inc
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
Site License
$4000
Enterprise License
$5000